Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma
- PMID: 16632427
- DOI: 10.1007/s12094-006-0169-7
Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma
Abstract
Purpose: Retrospectively analysed our experience in Renal Cell carcinoma (RCC) patients studied with 18-Fluorodeoxyglucose Positron Emission Tomography (FDG PET) to rule out the incidence and clinical impact of heart metastases.
Material and methods: In two years, 37 patients with RCC were studied with FDG PET. 10 were studied for initial staging and 27 patients were evaluated for suspected recurrence or re-staging.
Results: In two patients (5%), PET scan showed pathological focal uptake in myocardium. On the bases of this finding, MRI was performed visualizing a myocardial mass in both lesions and confirmed by histology in one of them. The hypothesis of prolepses of the tumour by thrombus in RCC patients justified the surgery.
Conclusion: Whole-body FDG PET in RCC patients could help to diagnose cardiac metastasis, and allows the possibility of therapeutic surgery, due to the thrombus significance of heart involvement.
Similar articles
-
Positron emission tomography imaging of renal vein and inferior vena cava tumor thrombus from renal cell carcinoma.Clin Nucl Med. 2005 Feb;30(2):107-9. doi: 10.1097/00003072-200502000-00009. Clin Nucl Med. 2005. PMID: 15647678 No abstract available.
-
Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.Clin Nucl Med. 2014 Sep;39(9):767-71. doi: 10.1097/RLU.0000000000000451. Clin Nucl Med. 2014. PMID: 24999677
-
A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.Nucl Med Commun. 2011 Apr;32(4):265-72. doi: 10.1097/MNM.0b013e3283442e3b. Nucl Med Commun. 2011. PMID: 21301376
-
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.Curr Urol Rep. 2019 Aug 29;20(10):56. doi: 10.1007/s11934-019-0932-2. Curr Urol Rep. 2019. PMID: 31468240 Review.
-
Positron emission tomography for prostate, bladder, and renal cancer.Semin Nucl Med. 2004 Oct;34(4):274-92. doi: 10.1053/j.semnuclmed.2004.06.004. Semin Nucl Med. 2004. PMID: 15493005 Review.
Cited by
-
A rare presentation of acute heart failure secondary to aggressive uterine leiomyosarcoma metastatic to the myocardium initially diagnosed as hypertrophic obstructive cardiomyopathy.Ann Transl Med. 2016 Oct;4(19):374. doi: 10.21037/atm.2016.09.34. Ann Transl Med. 2016. PMID: 27826577 Free PMC article.
-
A case of renal cell carcinoma with tumor thrombus extension into the right atrium.Ann Med Surg (Lond). 2025 May 21;87(6):3819-3822. doi: 10.1097/MS9.0000000000002837. eCollection 2025 Jun. Ann Med Surg (Lond). 2025. PMID: 40486613 Free PMC article.
-
Renal cell carcinoma with intramyocardial metastases.BMC Urol. 2014 Sep 6;14:73. doi: 10.1186/1471-2490-14-73. BMC Urol. 2014. PMID: 25193011 Free PMC article.
-
Photon-deficient Mass on FDG-PET Scan in Renal Cell Carcinoma: A Case Report.Clin Med Case Rep. 2008 Dec 23;2:1-4. doi: 10.4137/ccrep.s724. eCollection 2008. Clin Med Case Rep. 2008. PMID: 24179364 Free PMC article.
-
Recommendations on nuclear and multimodality imaging in IE and CIED infections.Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1795-1815. doi: 10.1007/s00259-018-4025-0. Epub 2018 May 24. Eur J Nucl Med Mol Imaging. 2018. PMID: 29799067
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical